Hims & Hers Health (HIMS) Accounts Payables (2019 - 2026)
Hims & Hers Health (HIMS) reported Accounts Payables of $306.9 million for Q1 2026, up 181.74% on a YoY basis from $108.9 million in Q1 2025, and up 114.17% sequentially from $143.3 million in Q4 2025.
Hims & Hers Health (HIMS) Accounts Payables (2019 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 8 years of Accounts Payables data on file, last reported at $306.9 million in Q1 2026.
- For the quarter ending Q1 2026, Accounts Payables rose 181.74% year-over-year to $306.9 million; the trailing twelve-month figure through Mar 2026 stood at $306.9 million (up 181.74% YoY), and the FY2025 full-year result was $143.3 million, up 57.14% from the prior year.
- Accounts Payables advanced to $306.9 million in Q1 2026, from $143.3 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $306.9 million in Q1 2026 to a low of $23.9 million in Q1 2022.
- A 5-year average of $82.8 million and a median of $43.9 million in 2024 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables gained 16.78% in 2024 and jumped 181.74% in 2026, its largest moves.
- Tracing HIMS's Accounts Payables over 5 years: stood at $32.4 million in 2022, then jumped by 33.08% to $43.1 million in 2023, then jumped by 111.7% to $91.2 million in 2024, then jumped by 57.14% to $143.3 million in 2025, then soared by 114.17% to $306.9 million in 2026.
- Business Quant data shows HIMS's Accounts Payables at $306.9 million in Q1 2026, $143.3 million in Q4 2025, and $198.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 498.30 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | 731,000.00 |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn | 306.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 306.87 Mn |
| Dec 31, 2025 | 143.28 Mn |
| Sep 30, 2025 | 198.41 Mn |
| Jun 30, 2025 | 105.01 Mn |
| Mar 31, 2025 | 108.92 Mn |
| Dec 31, 2024 | 91.18 Mn |
| Sep 30, 2024 | 75.44 Mn |
| Jun 30, 2024 | 57.10 Mn |
| Mar 31, 2024 | 43.92 Mn |
| Dec 31, 2023 | 43.07 Mn |
| Sep 30, 2023 | 42.00 Mn |
| Jun 30, 2023 | 38.27 Mn |
| Mar 31, 2023 | 37.61 Mn |
| Dec 31, 2022 | 32.36 Mn |
| Sep 30, 2022 | 32.97 Mn |
| Jun 30, 2022 | 27.09 Mn |
| Mar 31, 2022 | 23.91 Mn |
| Dec 31, 2021 | 19.64 Mn |
| Sep 30, 2021 | 16.09 Mn |
| Jun 30, 2021 | 15.56 Mn |